Therapeutic Options for the SARS-CoV-2 Virus: Is There a Key in Herbal Medicine?

被引：3

作者：

Sharma, Nitin ^{[1
]}

Kulkarni, Giriraj T. ^{[2
]}

Bhatt, Anant Narayan ^{[3
]}

Satija, Saurabh ^{[4
,5
]}

Singh, Lubhan ^{[6
]}

Sharma, Anjana ^{[7
]}

Dua, Kamal ^{[4
]}

Karwasra, Ritu ^{[8
]}

Khan, Asim Ali ^{[8
]}

Ahmad, Nadeem ^{[9
]}

Raza, Khalid ^{[10
]}

机构：

[1] ISF Coll Pharm, Dept Pharmaceut, Moga, Punjab, India

[2] Gokaraju Rangaraju Coll Pharm, Hyderabad, Telangana, India

[3] Def Res & Dev Org, Dept Nucl Med, Inst Nucl Med & Allied Sci, Delhi, India

[4] Univ Technol Sydney, Grad Sch Hlth, Discipline Pharm, Ultimo, NSW, Australia

[5] Lovely Profess Univ, Sch Pharmaceut Sci, Phagwara, Punjab, India

[6] Swami Vivekanand Subharti Univ, KharvelSubharti Coll Pharm, Dept Pharmacol, Meerut, Uttar Pradesh, India

[7] Meerut Inst Engn & Technol, Dept Pharmaceut Technol, Meerut, UP, India

[8] Govt India, Cent Council Res Unani Med CCRUM, Minist AYUSH, New Delhi, India

[9] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India

[10] Jamia Millia Islamia, Dept Comp Sci, New Delhi 110025, India

来源：

NATURAL PRODUCT COMMUNICATIONS | 2022年 / 17卷 / 09期

关键词：

SARS-CoV-2; herbal medicine; natural product; coronavirus; pneumonia; GLYCYRRHIZIC ACID; BETULINIC ACID; CORONAVIRUS SARS-COV-2; ENTEROVIRUS; 71; IN-VITRO; DERIVATIVES; PHARMACOLOGY; INHIBITORS; HESPERIDIN; LYCORINE;

D O I：

10.1177/1934578X221126303

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

SARS-CoV-2 has been responsible for over 500 million cumulative cases all over the world since December 2019 and has marked the third introduction of a highly pathogenic virus after SARS-CoV and MERS-CoV. This virus is in a winning situation because scientists are still racing to explore effective therapeutics, vaccines, and event treatment regimens. In view of progress in current disease management, until now none of the preventive/treatment measures can be considered entirely effective to treat SARS-CoV-2 infection. Therefore, it is required to look up substitute ways for the management of this disease. In this context, herbal medicines could be a good choice. This article emphasizes the antiviral potential of some herbal constituents which further can be a drug of choice in SARS-CoV-2 treatment. This article may be a ready reference for discovering natural lead compounds and targets in SARS-CoV-2 associated works.

引用

页数：10

共 92 条

[1] Abbassy Moustafa A., 1998, Journal of the Egyptian Society of Parasitology, V28, P197
[2] RETRACTED: Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment? (Retracted Article)
Agrawal, Pawan K.
Agrawal, Chandan
Blunden, Gerald
[J]. MOLECULES, 2022, 27 (12):
[3] Pharmacological Significance of Hesperidin and Hesperetin, Two Citrus Flavonoids, as Promising Antiviral Compounds for Prophylaxis Against and Combating COVID-19
Agrawal, Pawan K.
Agrawal, Chandan
Blunden, Gerald
[J]. NATURAL PRODUCT COMMUNICATIONS, 2021, 16 (10)
[4] Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies
Ahmed, Md Nasir
Jahan, Rownak
Nissapatorn, Veeranoot
Wilairatana, Polrat
Rahmatullah, Mohammed
[J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 146
[5] Glycyrrhizin as antiviral agent against Hepatitis C Virus
Ashfaq, Usman A.
Masoud, Muhammad S.
Nawaz, Zafar
Riazuddin, Sheikh
[J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
[6] Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks
Ashour, Hossam M.
Elkhatib, Walid F.
Rahman, Md. Masudur
Elshabrawy, Hatem A.
[J]. PATHOGENS, 2020, 9 (03):
[7] Glycyrrhizic acid derivatives as influenza A/H1N1 virus inhibitors
Baltina, Lidia A.
Zarubaev, Vladimir V.
Baltina, Lia A.
Orshanskaya, Iana A.
Fairushina, Alina I.
Kiselev, Oleg I.
Yunusov, Marat S.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (08) : 1742 - 1746
[8] Natural Products Isolated from Oriental Medicinal Herbs Inactivate Zika Virus
Batista, Mariana N.
Braga, Ana Claudia S.
Fernandes Campos, Guilherme Rodrigues
Souza, Marcos Michel
Adum de Matos, Renata Prandini
Lopes, Tairine Zara
Candido, Natalia Maria
Duarte Lima, Maria Leticia
Machado, Francielly Cristina
Queiroz de Andrade, Stephane Tereza
Bittar, Cintia
Nogueira, Mauricio L.
Carneiro, Bruno M.
Mariutti, Ricardo B.
Arni, Raghuvir Krishnaswamy
Calmon, Marilia Freitas
Rahal, Paula
[J]. VIRUSES-BASEL, 2019, 11 (01):
[9] Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis
Bhowmik, Deep
Nandi, Rajat
Prakash, Amresh
Kumar, Diwakar
[J]. HELIYON, 2021, 7 (03)
[10] Carlos WG, 2020, AM J RESP CRIT CARE, V201, pP7, DOI 10.1164/rccm.2014P7

← 1 2 3 4 5 6 7 8 9 10 →